Loading...

RBC Lysis Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Red blood cell lysis buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420301 100 mL 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
420302 500 mL 165€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Red Blood Cell (RBC) Lysis Buffer has been designed, formulated, and tested to ensure optimal lysis of RBCs in single cell suspensions with minimal effects on leukocytes. RBC Lysis Buffer is supplied as a 10X solution containing ammonium chloride, potassium carbonate, and EDTA, and should be diluted in deionized water prior to use. Nucleated RBCs are not effectively lysed with ammonium chloride. Test

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
This red blood cell (RBC) lysis buffer is supplied as a 10X solution and should be diluted to 1X in deionized water. 100 ml of 10X concentrate will yield a quantity of 1X solution that is sufficient to lyse 500 samples.
Preparation
The pH of the 1X solution should fall within the range of pH 7.1-7.4. Adjust the pH if necessary. Warm the 1X solution to room temperature prior to use.
Storage & Handling
Store RBC lysis buffer between 2°C and 8°C.
Application Notes

A. Lysis of Mouse Spleen RBCs:
1. Harvest mouse spleen and prepare a single cell suspension.
2. Pellet the cells by centrifugation (350 x g); aspirate the supernatant.
3. Dilute the 10X Red Blood Cell Lysis Buffer to 1X working concentration with deionized water and resuspend the pellet in 5 ml of 1X Lysis Buffer.
4. Incubate on ice for 4-5 minutes with occasional shaking.
5. Stop the reaction by diluting the Lysis Buffer with 20-30 ml of 1X PBS.
6. Spin the cells (350 x g) and discard the supernatant.
7. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer Cat. No. 420201), wash 1X.
8. Count cells, adjust density, and proceed with cell staining procedures.
B. Lysis of Human Peripheral Blood RBCs:
1. Dilute the 10X RBC Lysis Buffer to 1X working concentration with deionized water. Warm the 1X solution to room temperature prior to use.
2. Add 2.0 ml of 1X RBC Lysis Buffer to each tube containing up to 100 µl of whole blood.
3. Gently vortex each tube immediately after adding the lysing solution. Incubate at room temperature, protected from light, for 10-15 minutes.
4. Centrifuge 350 x g for 5 minutes. Aspirate supernatant without disturbing pellet.
5. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer, Cat. No. 420201), wash 1X.
6. Resuspend and proceed with further procedures.

Application References

(PubMed link indicates BioLegend citation)
  1. Adams RA, et al. 2007. J. Exp. Med. 204:571.
  2. Feild-Corbett C, et al. 2009. Stem Cells. PubMed
  3. de Resende MM, et al. 2010. Physiol Genomics. 42:437. PubMed
  4. Roybal JD, et al. 2011. Mol Cancer Res. 9:25. PubMed
  5. Boldin MP, et al. 2011. J Exp Med. PubMed
  6. Kahlenberg JM, et al. 2011. J. Immunol. 187:6143. PubMed
  7. Deiuliis JA, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:399. PubMed
  8. Wu CY, et al. 2012. PLoS One. 7:e42365. PubMed
  9. Hsia BJ, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  10. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  11. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. PubMed
  12. Saraiva AM, 2013. Hum Immunol. 74:207. PubMed
  13. Koon HW, et al. 2013. J Vis exp. 68:4208. PubMed
  14. Ma Dy, et al. 2013. J Virol. 87:3361. PubMed
  15. Han W, 2013. J. Immunol. 190:4786. PubMed
  16. Garcia-Acros I, et al. 2013. J Biol Chem. 288:14046. PubMed
  17. Zhao JL, et al. 2013. Elife. 21:537. PubMed
  18. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. PubMed
  19. Yamasaki S, et al. 2013. Clin Vaccine immunol. 20:1508. PubMed
  20. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  21. Liu X, et al. 2013. Invest Ophthalmol Vis Sci. 54:7386. PubMed
  22. Fullerton AM, et al. 2013. Toxicol Sci. 136:72. PubMed
  23. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  24. Varga T, et al. 2013. J. Immunol. 191:5695. PubMed
  25. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  26. Chang YJ, et al. 2014. Cytotherapy. 16:560. PubMed
  27. Kim MJ, et al. 2014. Mol Pharmacol. 86:284. PubMed
  28. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  29. Szulzewsky F, et al. 2015. PloS One. 10:116644. PubMed
Product Citations
  1. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  2. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  3. Sandovici I, et al. 2022. Dev Cell. 57:63. PubMed
  4. Deiuliis J, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:L399. PubMed
  5. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. . PubMed
  6. Barros-Martins J, et al. 2016. J Immunol. 196: 3642 - 3652. PubMed
  7. Zhou B, et al. 2020. Nat Immunol. 1.868055556. PubMed
  8. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  9. Asem M, et al. 2020. Cancer Res. 1156:80. PubMed
  10. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  11. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  12. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  13. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  14. Pracht K, et al. 2021. Eur J Immunol. 51:1089. PubMed
  15. Radwanska M, et al. 2020. Methods Mol Biol. 2116:721. PubMed
  16. Rendon CJ, et al. 2022. Front Endocrinol (Lausanne). 13:995499. PubMed
  17. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  18. Della Verde G, et al. 2022. Life Sci Alliance. 5:. PubMed
  19. Su C, et al. 2021. Front Oncol. 11:719564. PubMed
  20. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  21. Chen Z, et al. 2020. Glia. 68:2148. PubMed
  22. Seow JJW, et al. 2021. Front Med (Lausanne). 8:603374. PubMed
  23. Shin J, et al. 2020. Hum Gene Ther. . PubMed
  24. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  25. Spengler J, et al. 2016. J Infect Dis. 214: S308 - S318. PubMed
  26. Zheng M, et al. 2016. J Immunol. 196: 4122 - 4131. PubMed
  27. St-Pierre S, et al. 2016. PLoS One. 11: 0150230. PubMed
  28. Ensan S, et al. 2015. Nat Immunol. 17: 159-168. PubMed
  29. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  30. Hou J, et al. 2015. J Mol Cell Biol. 7: 338-350. PubMed
  31. Fujii H, et al. 2015. PLoS One. 10: 0133216. PubMed
  32. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  33. Zhang J, et al. 2021. Aging (Albany NY). 13:17880. PubMed
  34. Press AT, et al. 2021. EMBO Mol Med. 13:e14436. PubMed
  35. Sima LE, et al. 2021. J Immunother Cancer. 9:. PubMed
  36. Ma H, et al. 2021. Front Immunol. 12:760095. PubMed
  37. McGill CJ, et al. 2021. STAR Protoc. 2:100948. PubMed
  38. Lutze J, et al. 2022. Methods Mol Biol. 2394:299. PubMed
  39. Hosseini A, et al. 2022. Evid Based Complement Alternat Med. 2022:5639226. PubMed
  40. Bikorimana JP, et al. 2022. Cell Rep Med. 3:100534. PubMed
  41. Zhang L, et al. 2022. JCI Insight. 7:. PubMed
  42. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  43. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  44. Magalhães L, et al. 2015. PLoS Negl Trop Dis. 10: 0003816. PubMed
  45. Moraes-Vieira P, et al. 2016. Diabetes. 65: 1317 - 1327. PubMed
  46. Garcia-Fabiani MB, et al. 2020. STAR Protoc. :1. PubMed
  47. Liu W, et al. 2017. Int J Environ Res Public Health. 10.3390/ijerph14060592. PubMed
  48. Pietrocola F, et al. 2017. Autophagy. 0.935416667. PubMed
  49. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  50. Wang J, et al. 2020. Sci Rep. 10:12785. PubMed
  51. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  52. Wu Y, et al. 2021. Nat Biomed Eng. 5:1336. PubMed
  53. Meng S, et al. 2022. Exp Anim. . PubMed
  54. Kokkinopoulos I, et al. 2021. Sci Rep. 11:15759. PubMed
  55. Johnson CL, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H756. PubMed
  56. Stringhini M, et al. 2021. MAbs. 13:1868066. PubMed
  57. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  58. Elisabeth Schrumpf, Xiaojun Jiang 2017. Physiol Rep. 10.14814/phy2.13117. PubMed
  59. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  60. Brunmeir R, et al. 2016. PLoS Genet. 12:e1006474. PubMed
  61. Pridans C, et al. 2016. J Immunol. 197: 2297 - 2305. PubMed
  62. Mircheff A, et al. 2016. Ocul Surf. 14:460-483. PubMed
  63. Pennington L, et al. 2016. Nat Commun. 7:11610. PubMed
  64. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  65. Boldin M, et al. 2011. J Exp Med. 208:1189. PubMed
  66. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  67. Bravo–San Pedro JM, et al. 2019. Cell Metab. 30:754. PubMed
  68. Clark EL, et al. 2017. PLoS Genet. 13:e1006997. PubMed
  69. Cantor JR, et al. 2017. Cell. 169:258. PubMed
  70. Ji WJ, et al. 2017. Cytometry B Clin Cytom. 92:371. PubMed
  71. Zhai Z, et al. 2021. Medicine (Baltimore). 100:e26214. PubMed
  72. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  73. Jones N, et al. 2021. Nat Commun. 12:1209. PubMed
  74. Wang D, et al. 2021. Signal Transduct Target Ther. 6:376. PubMed
  75. Machado H, et al. 2021. PLoS Pathog. 17:e1009933. PubMed
  76. Yan X, et al. 2022. Int J Biol Sci. 18:585. PubMed
  77. Singh SS, et al. 2021. Eur J Med Chem. 216:113312. PubMed
  78. Pokhrel RH, et al. 2022. Int J Mol Sci. 23:. PubMed
  79. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  80. Hamour S, et al. 2015. PLoS One. 10: 0136238. PubMed
  81. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  82. Luo B, et al. 2016. J Neurosci. 36: 9590 - 9603. PubMed
  83. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  84. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  85. Sakamoto S, et al. 2020. OncoImmunology. 8(12):e1671760.. PubMed
  86. Mo L, et al. 2022. Front Oncol. 12:871489. PubMed
  87. Huang L, et al. 2021. J Cell Physiol. 236:7308. PubMed
  88. Whytock KL, et al. 2022. iScience. 25:104772. PubMed
  89. Neufeld L, et al. 2021. Sci Adv. 7:. PubMed
  90. Friedman G, et al. 2020. Nat Cancer. 1:692. PubMed
  91. Kumar A, et al. 2021. Part Fibre Toxicol. 18:43. PubMed
  92. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  93. Scherer SD, et al. 2021. Breast Cancer Res. 23:100. PubMed
  94. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  95. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  96. Orr AN, et al. 2021. Int J Mol Sci. 22:. PubMed
  97. Facchini M, et al. 2014. J Vis Exp. 85: 51019. PubMed
  98. Ilievski V, et al. 2015. PLoS One. 10: 0136502. PubMed
  99. Saraiva A, et al. 2013. Hum Immunol. 74:207. PubMed
  100. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  101. Jiang J, et al. 2018. Cancer Med. 3.504861111. PubMed
  102. Chen Z, et al. 2017. Cancer Res. 77:2266. PubMed
  103. Kim M, et al. 2017. Int J Mol Sci. 10.3390/ijms18061275. PubMed
  104. Kildisiute G, et al. 2021. Sci Adv. 7: . PubMed
  105. Schiferle EB, et al. 2021. Sci Adv. 7: . PubMed
  106. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  107. Bigenwald C, et al. 2021. Nat Med. 27:851. PubMed
  108. Gingrich AA, et al. 2021. Front Immunol. 12:670309. PubMed
  109. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  110. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  111. Vivanco Gonzalez N, et al. 2022. STAR Protoc. 3:101280. PubMed
  112. Qin L, et al. 2022. Nat Commun. 13:6051. PubMed
  113. Escudero-Lara A, et al. 2022. Front Behav Neurosci. 16:946975. PubMed
  114. Han W, et al. 2013. J Immunol. 190:4786. PubMed
  115. Yamasaki S, et al. 2013. Clin Vaccine Immunol. 20:1508. PubMed
  116. Fukui R, et al. 2016. J Immunol. 196: 416 - 427. PubMed
  117. Rodriguez-Garcia M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.72. PubMed
  118. Wang K, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.016. PubMed
  119. Appelbe O, et al. 2017. J Control Release.. 10.1016/j.jconrel.2017.09.043. PubMed
  120. Tang J, et al. 2017. Proc Natl Acad Sci U S A. 114:E7441. PubMed
  121. Liccardi G, et al. 2019. Mol Cell. 73:413. PubMed
  122. Patil R, et al. 2019. J Biomed Opt. 24:1. PubMed
  123. Ongaro T, et al. 2020. Oncotarget. 3.026388889. PubMed
  124. Kahlenberg J, et al. 2011. J Immunol. 187:6143. PubMed
  125. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  126. Evans AK, et al. 2020. Neurobiol Dis. 146:105089. PubMed
  127. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  128. Choi JW, et al. 2020. PLoS One. 15:e0235518. PubMed
  129. Alban TJ, et al. 2020. Front Immunol. 1.285416667. PubMed
  130. Jiang S, et al. 2017. Toxicology Lett. 10.1016/j.toxlet.2017.03.015. PubMed
  131. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  132. Martínez-Muriana A, et al. 2020. Stem Cell Res Ther. 11:53. PubMed
  133. Pennig J, et al. 2019. Sci Rep. 9:17937. PubMed
  134. Wang B, et al. 2017. Stem Cell Res Ther.. 10.1186/s13287-017-0744-6. PubMed
  135. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  136. Yu Z, et al. 2021. Front Oncol. 11:659251. PubMed
  137. Deng J, et al. 2021. Nat Cancer. 2:503. PubMed
  138. Beaudoin-Bussières G, et al. 2022. Cell Rep. 38:110368. PubMed
  139. Hu H, et al. 2021. Cancer Immunol Res. 9:1298. PubMed
  140. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  141. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  142. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  143. Garcia-Arcos I, et al. 2013. J Biol Chem. 288:14046. PubMed
  144. Sci T 2013. Toxicol Sci. 136:72. PubMed
  145. Metz H, et al. 2016. Proc Natl Acad Sci U S A. 113: 8795 - 8800. PubMed
  146. Cheng Q, et al. 2020. Nat Nanotechnol. 0.842361111. PubMed
  147. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  148. Alghamri MS, et al. 2020. Methods Enzymol. 632:215. PubMed
  149. Elphinstone R, et al. 2017. Infect Immun. 10.1128/IAI.00371-17. PubMed
  150. Kernfeld EM, et al. 2018. Immunity. 48:1258. PubMed
  151. Nwani NG, et al. 2019. Cancers (Basel). 0.806944444. PubMed
  152. Ramalingam P, et al. 2020. Nat Commun. 11:666. PubMed
  153. Tavakol DN, et al. 2021. Curr Protoc. 1:e275. PubMed
  154. Ullah I, et al. 2021. Immunity. 54:2143. PubMed
  155. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  156. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  157. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  158. Meng YM, et al. 2021. Nat Commun. 12:6011. PubMed
  159. Zhu QY, et al. 2021. Nat Commun. 12:6624. PubMed
  160. Patel M, et al. 2021. Cancer Res. 81:3985. PubMed
  161. Shi X, et al. 2021. Nat Commun. 12:2547. PubMed
  162. Ramaswamy G, et al. 2017. Sci Rep. 10.1038/srep45140. PubMed
  163. Lizotte P, et al. 2016. Sci Rep. 6:31745. PubMed
  164. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  165. Rosenbluth JM, et al. 2020. Nat Commun. 11:1711. PubMed
  166. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  167. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  168. Pace J, et al. 2022. J Biomed Opt. 27:. PubMed
  169. Pedicona F, et al. 2022. Sci Signal. 15:eabl7989. PubMed
  170. Fidalgo MF, et al. 2022. Life Sci Alliance. 5:. PubMed
  171. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  172. Zhao J, et al. 2013. Elife. 21:537. PubMed
  173. Weber G, et al. 2015. Surgery. 158: 248-254. PubMed
  174. Jiang H, et al. 2016. Nat Med. 10.1038/nm.4123. PubMed
  175. Elgueta R, et al. 2016. J Immunol. 197: 3970 - 3981. PubMed
  176. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  177. Wen J, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0489-9. PubMed
  178. Ahmad S,et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. . 10.1016/j.pnpbp.2017.10.001. PubMed
  179. Hang J, et al. 2019. Cancer Med. 1.254166667. PubMed
  180. Tan X, et al. 2019. Sci Rep. 2.7125. PubMed
  181. Lienemann PS, et al. 2020. Adv Sci (Weinh). 7:1903395. PubMed
  182. Yan Q, et al. 2022. Clin Transl Med. 12:e1084. PubMed
  183. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  184. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  185. Castoldi F, et al. 2020. Cell Death Discov. 0.339583333. PubMed
  186. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  187. Morris C, et al. 2017. MBio. 10.1128/mBio.00036-17. PubMed
  188. Theurl I, et al. 2016. Nat Med. 10.1038/nm.4146. PubMed
  189. Schweppe RE, et al. 2019. Mol Cancer Res. 17:1036. PubMed
  190. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  191. Yang A, et al. 2018. Cancer Discov. 0.525. PubMed
  192. Rentsendorj A, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.08.019. PubMed
  193. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  194. Ito T, et al. 2021. Nat Commun. 12:2232. PubMed
  195. Hollerbach A, et al. 2021. J Thromb Haemost. . PubMed
  196. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  197. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  198. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  199. Majumdar D, et al. 2021. Curr Protoc. 1:e216. PubMed
  200. Michelotti TC, et al. 2022. Front Cell Dev Biol. 10:1025240. PubMed
  201. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  202. Varga T, et al. 2013. J Immunol. 191:5695. PubMed
  203. Samuelson D, et al. 2016. J Immunol. 196: 2655 - 2665. PubMed
  204. Tsao P, et al. 2016. Proc Natl Acad Sci U S A. 113: 8242 - 8247. PubMed
  205. Soncini M, et al. 2016. Proc Natl Acad Sci U S A. 113: E6219 - E6227. PubMed
  206. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  207. Nowyhed H, et al. 2017. Sci Rep. 7:40273. PubMed
  208. De Domenico E, et al. 2020. STAR Protoc. 1:100233. PubMed
  209. Wang Z, et al. 2020. Cell Rep. 33:108472. PubMed
  210. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  211. Dyck S, et al. 2018. J Neuroinflammation. 0.6875. PubMed
  212. Yang YS, et al. 2020. Mol Ther Methods Clin Dev. 17:922. PubMed
  213. Gangwar RS, et al. 2020. Sci Rep. 10:14348. PubMed
  214. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  215. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  216. Xiang Y, et al. 2022. Skelet Muscle. 12:19. PubMed
  217. Yamazaki T, et al. 2021. Oncoimmunology. 10:1962592. PubMed
  218. Zhang J, et al. 2020. Pain. 161:1381. PubMed
  219. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  220. Canali S, et al. 2017. Blood. 129(4):405-414. PubMed
  221. Shen X, et al. 2016. Sci Rep. 6:38778. PubMed
  222. Sauter K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G533 - G547. PubMed
  223. Song C, et al. 2015. Blood. 126: 1813 - 1822. PubMed
  224. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  225. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  226. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  227. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  228. Bowers J, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01221. PubMed
  229. Tulasi DY, et al. 2021. Cell Mol Gastroenterol Hepatol. 11:1437. PubMed
  230. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  231. Xue X, et al. 2021. Cent Eur J Immunol. 46:191. PubMed
  232. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  233. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  234. Ma D, et al. 2013. J Virol. 87:3361. PubMed
  235. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  236. Kim M, et al. 2014. Mol Pharmacol. 86:284. PubMed
  237. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  238. Pankova D, et al. 2016. Mol Cancer Res. 14: 287 - 295. PubMed
  239. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  240. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  241. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  242. Bichsel C, et al. 2017. Sci Rep. 10.1038/s41598-017-09928-1. PubMed
  243. James M, et al. 2017. J Nucl Med. . 10.2967/jnumed.117.189597. PubMed
  244. Annibaldi A, et al. 2018. Mol Cell. 69:566. PubMed
  245. Hill SJ, et al. 2018. Cancer Discov. 1.308333333. PubMed
  246. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  247. Soileau AM, et al. 2022. Vet Sci. 9:. PubMed
  248. McClellan BL, et al. 2022. STAR Protoc. 3:101357. PubMed
  249. Governa V, et al. 2022. Proc Natl Acad Sci U S A. 119. PubMed
  250. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  251. Mai CL, et al. 2021. Theranostics. 11:1059. PubMed
  252. Chen P, et al. 2021. Clin Transl Med. 11:e462. PubMed
  253. Peng X, et al. 2021. Stem Cell Res Ther. 198:12. PubMed
  254. Linder A, et al. 2020. EMBO J. 39:e105071. PubMed
  255. Muñoz-Ruiz M, et al. 2016. Nat Immunol. 10.1038/ni.3424. PubMed
  256. Chang Y, et al. 2014. Cytotherapy. 16:560. PubMed
  257. Hsia B, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  258. Resende M, et al. 2010. Physiol Genomics. 42:437. PubMed
  259. McLaughlin S, et al. 2019. Nat Commun. 3.795833333. PubMed
  260. Koury J, et al. 2019. PLoS One. 14:e0218670. PubMed
  261. Zhang Z, et al. 2017. Journal of Translational Medicine. 10.1186/s12967-017-1196-6. PubMed
  262. Cordo' V, et al. 2022. Nat Commun. 13:1048. PubMed
  263. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  264. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  265. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  266. Nagree MS, et al. 2022. EMBO Mol Med. 14:e14297. PubMed
  267. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  268. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. . PubMed
  269. Liu Y, et al. 2015. Sci Rep. 5: 15134. PubMed
  270. Hodson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 2039-2046. PubMed
  271. Munson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 8272 - 8277. PubMed
  272. Ubellacker J, et al. 2017. Breast Cancer Res. 10.1186/s13058-017-0815-8. PubMed
  273. DU T, et al. 2020. Front Immunol. 1.571527778. PubMed
  274. Trial J, et al. 2020. Geroscience. . PubMed
  275. Mochizuki M,et al. 2017. J Am Heart Assoc. . 10.1161/JAHA.117.005920. PubMed
  276. Roh–Johnson M, et al. 2017. Dev Cell. 43:549. PubMed
  277. Müller C, et al. 2018. Elife. 7:e34985. PubMed
  278. Visweshwaran SP, et al. 2022. Front Cell Dev Biol. 10:1008898. PubMed
  279. Li Q, et al. 2022. Signal Transduct Target Ther. 7:222. PubMed
  280. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  281. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  282. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  283. Wu R, et al. 2020. J Immunother Cancer. 8:00. PubMed
  284. Yu H, et al. 2016. Sci Rep. 6:35190. PubMed
  285. Now H, Yoo J 2016. Cell Mol Immunol. 10.1038/cmi.2016.32. PubMed
  286. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  287. YC S, SJ L 2015. Sci Rep. 5: 12578. PubMed
  288. Szulzewsky F, et al. 2015. PLoS One. 10:116644. PubMed
  289. Wu C, et al. 2012. PLoS One. 7:e42363. PubMed
  290. Denning W, et al. 2011. PLoS One. 6:e16897. PubMed
  291. Weaver J, et al. 2017. Part Fibre Toxicol. 10.1186/s12989-017-0206-4. PubMed
  292. Samuelson D, et al. 2017. PLoS Pathogens. 13(6):e1006426. PubMed
  293. Wong C, et al. 2017. J Immunol. 10.4049/jimmunol.1700397. PubMed
  294. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  295. Park HJ, et al. 2021. Int J Mol Sci. 22:. PubMed
  296. Cebrian-Silla A, et al. 2021. Elife. 10:. PubMed
  297. Yeini E, et al. 2021. Nat Commun. 12:1912. PubMed
  298. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  299. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  300. Kucykowicz S, et al. 2022. STAR Protoc. 3:101356. PubMed
  301. Kim TW, et al. 2022. Mol Ther Oncolytics. 26:1. PubMed
  302. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  303. Shaashua L, et al. 2022. Nat Commun. 13:6513. PubMed
  304. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  305. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  306. Roybal J, et al. 2011. Mol Cancer Res. 9:25. PubMed
  307. Roy IM, et al. 2021. Bio Protoc. 11:e4130. PubMed
  308. Alam A, et al. 2022. STAR Protoc. 3:101563. PubMed
  309. Xiang Y, et al. 2022. Exp Mol Med. 54:1011. PubMed
  310. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  311. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  312. Wahane S, et al. 2021. Sci Adv. 7:. PubMed
  313. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  314. Huang N, et al. 2021. Nat Med. 27:892. PubMed
  315. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  316. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  317. Erady C, et al. 2021. NPJ Genom Med. 6:04. PubMed
  318. de Silva S, et al. 2020. Cancer Immunol Res. 0.493055556. PubMed
  319. Wan C, et al. 2021. Cancer Res. 81:158. PubMed
  320. Wang X, et al. 2016. J Virol. 90: 10247 - 10258. PubMed
  321. Mohammed R, et al. 2016. Cell Rep. 14:760-771. PubMed
  322. Durward-Diioia M, et al. 2015. Infect Immun . 83: 4759 - 4771. PubMed
  323. Birnie K, et al. 2015. Mol Cancer Res. 13: 1106 - 1118. PubMed
  324. Liu X, et al. 2013. Invest Ophthalmol Vis Sci . 54:7386. PubMed
  325. Field-Corbett C, et al. 2009. Stem Cells. 27:662. PubMed
  326. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  327. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  328. Tomas C, et al. 2019. Sci Rep. 9:11464. PubMed
  329. Kim JK, et al. 2019. Bioengineering (Basel). 6:24. PubMed
  330. Alizadeh A, et al. 2018. J Neuroinflammation. 15:53. PubMed
  331. Guo P, et al. 2017. J Clin Invest. 127:4242. PubMed
  332. Tsai SC, et al. 2017. Biomicrofluidics. 11:034122. PubMed

Antigen Details

Cell Type
Tregs
Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 06.10.2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account